Work Shield, the Dallas-based startup behind technology for reporting, investigating, and resolving harassment and discrimination in the workplace, has closed on a $4.11 million Series A funding round. The financing was led by Dallas-based Hoak & Co. in partnership with …
Frisco-based Trivie, a training and communication startup that helps companies better engage their workforce in knowledge retention and communication, has closed $5 million in Series A funding to increase distribution of its app.
dallasinnovates.com/frisco-based-trivie-closes-5m-series-a-to-expand-its-workforce-knowledge-retention-platform/…
Following a Series A funding round of $5.2 million in January, OneDay has now launched its pivotal new product. And, it was named one of Inc.’s Best Workplaces of 2020 and has grown 90 percent in the past 90 days.…
BALANCED has announced closing a $3.5 million seed funding round. A number of Dallas investors participated in the round, according to CEO Robert Atkins. That includes Dr. Bobby Lyle, who became interested after following BALANCED’s work at SMU Guildhall and …
A Dallas biotechnology startup will hire more cancer researchers, biologists and artificial intelligence developers with the $26 million it raised in an initial public stock offering this week.
www.dallasnews.com/business/health-care/2020/06/16/biotech-startup-lantern-pharmas-ipo-yields-26-million-for-its-cancer-drug-development/…
Plano-based Reata Pharmaceuticals Inc. is getting a $350 million infusion from a Wall Street titan to aid in bringing its chronic kidney disease drug to the commercial market.
www.dallasnews.com/business/health-care/2020/06/11/plano-based-reatas-stock-soars-26-after-scoring-350-million-investment-from-blackstone/…
Dallas-based biotech Taysha Gene Therapies has emerged out of stealth with a $30 million seed round and a new strategic partnership with UT Southwestern. The company aims to end severe and life-threatening diseases of the central nervous system caused by …
Peak Nanosystems LLC, a global company headquartered in Coppell that specializes in the development and deployment nanotechnology systems, has closed its Series C funding round with a $25 million investment from Connecticut-based Squadron Capital. The new money is two-fold: Peak …
Dallas biopharmaceutical company ReCode Therapeutics has received an oversubscribed $80 million Series A investment-the largest funding round this year in Dallas-Fort Worth-that it will use to bring new lung disease drugs to market. The company said that it will file …
Allied BioScience (ABS), a Dallas-based biotechnology company specializing in antimicrobial coatings for public spaces, announced that it is among Lydia Partners’ initial round of multimillion-dollar investments in consumer technology, healthcare, and biomedical ventures. The capital will be used to scale …
